Key facts
- Epihunter’s last known valuation is $4.5M (Oct 2025).
- It has raised $3.2M; the latest was Later Stage VC ($1.9M) in Oct 2025.
- Notable investors include MassChallenge, Imec.istart, BlueHealth Innovation Centre, Business Angels Network Vlaanderen, Corda Campus — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Epihunter
- ·The full record, as it builds
Funding rounds
No funding rounds for Epihunter are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Epihunter
Developer of a medical monitoring device designed to monitor epilepsy in children and adults. The company's device uses advanced medical technologies to detect, signal, and register absence epilepsy seizures in real-time, enabling epilepsy patients to experience less impact from their condition and receive a diagnosis earlier and optimized treatment.
- Sector
- Healthcare
- HQ
- Hasselt, Belgium
- Founded
- 2017
- Employees
- 6
- Website
- epihunter.com/
- Ownership
- Privately Held (backing)
Epihunter doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Epihunter shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Epihunter in its N-PORT filings yet. We sweep new filings monthly.